(312) 275-5850 9-5pm CST
0 CART $0.00
Your shopping cart is empty.
CIA Medical Google Customer Reviews – Central Infusion Alliance
CIA Medical BBB Accredited A+ Business – Central Infusion Alliance
CIA Medical Digicert EV Secure – Central Infusion Alliance
Menu

BD 20558E - SmartSite Tri-Port Connector, 0.46 mL PV, Needle-Free IV Access Connector, 50/CS (Continental US Only)

BD  # 20558E - SmartSite Tri-Port Connector, 0.46 mL PV, Needle-Free IV Access Connector, 50/CS (Continental US Only)
Part Number BD 20558E
SKU Number CIA8042293
Sell Unit CASE
Ships Within Special Order
List Price $463.63
Enter a valid quantity
Product Description

BD 20558E - SmartSite Tri-Port Connector, 0.46 mL PV, Needle-Free IV Access Connector, 50/CS (Continental US Only)

The BD 20558E SmartSite Tri-Port Connector is a sterile needle-free IV connector designed to support secure, efficient access for fluid administration, medication delivery, direct injection, intermittent infusion, and continuous infusion. Its tri-port configuration provides multiple access points in a compact connector format, helping clinicians manage compatible IV therapy workflows with fewer separate connection components.

This connector is commonly listed by distributors as a SmartSite Tri-Port Connector with 0.46 mL priming volume and 50 units per case. BDs current official product page for SKU 20558E lists the product as a SmartSite tri-port connector with an approximate priming volume of 0.6 mL, 6 cm approximate length, two connectors, and a fluid path sterile configuration. Buyers should confirm the priming volume shown on current product labeling before purchase or clinical use.

ManufacturerApplicationType
20558ENeedleless ConnectorNegative Displacement

Key Benefits

  • Needle-free connector design helps reduce unnecessary needle handling during IV access and medication administration.
  • Tri-port configuration supports multiple compatible access points through one compact connector.
  • SmartSite design enables direct injection, intermittent infusion, and continuous infusion when used with compatible systems.
  • Clear fluid path supports visual inspection and helps clinicians confirm line condition during setup and use.
  • Compact connector profile helps support organized IV line management near the patient access site.
  • Sterile fluid path supports safe clinical use when handled with aseptic technique.
  • Not made with natural latex, supporting use in facilities managing latex-sensitive patient care environments. :contentReference[oaicite:1]{index=1}
  • Case packaging supports supply planning for hospitals, infusion centers, and high-use clinical departments.

Compatibility and Applications

The BD 20558E is intended for use with compatible IV access systems, administration sets, extension sets, syringes, and infusion components that support SmartSite needle-free connection workflows. It is suitable for clinical settings where secure needle-free access is needed for medication delivery, IV fluid administration, line access, and infusion management.

This connector is commonly used in hospitals, outpatient infusion centers, oncology clinics, emergency departments, surgical centers, ambulatory care facilities, and specialty care environments. Typical applications include direct medication injection, intermittent infusion, continuous infusion access, line connection management, and multi-access IV therapy workflows.

Usage Guidelines

  • Inspect the package before use and do not use the product if the sterile barrier is damaged, opened, or compromised.
  • Confirm that the product reference number, connector type, priming volume, and configuration match the intended clinical application.
  • Use aseptic technique when opening, handling, connecting, accessing, or disconnecting the connector.
  • Disinfect the access surface according to facility policy before each use.
  • Verify compatibility with the medication, syringe, administration set, extension set, catheter access device, and infusion method before use.
  • Prime the connected fluid path as required by the clinical setup and facility protocol.
  • Trace IV lines before administration to help prevent misconnections.
  • Do not reuse, reprocess, or resterilize the connector unless product labeling specifically permits it.
  • Dispose of the connector after use according to facility medical waste procedures.

Certifications, Safety Standards, and Regulatory Approvals

BD lists SKU 20558E as a SmartSite tri-port connector with fluid path sterile status, no natural latex, registered with Health Canada, not CE marked, and manufactured in Mexico. BD also lists GTIN each 10885403234958, GTIN case 50885403234956, GTIN shelfpack 20885403234955, and a case quantity of 50. :contentReference[oaicite:2]{index=2}

These specifications help procurement teams verify product identity, packaging format, regulatory suitability, and facility purchasing requirements. Healthcare organizations should confirm current labeling, instructions for use, lot status, and local regulatory requirements directly through BD or an authorized distributor before implementation.

Comparison with Competitor Products

The BD 20558E is best compared with other needle-free IV connectors and multi-port access connectors from manufacturers such as B Braun, ICU Medical, Baxter, and other infusion therapy suppliers. Compared with single-port needle-free connectors, the BD SmartSite tri-port configuration provides multiple access points in one connector, which may help streamline compatible IV therapy workflows.

Compared with basic luer caps or conventional access components, the SmartSite needle-free format supports needle-free injection and infusion access, helping reduce unnecessary sharps handling. Compared with extension sets that include tubing, this product is a connector-only solution, making it useful when clinicians need access functionality without adding tubing length or additional line volume.

For facilities already standardized around BD SmartSite components, the BD 20558E may offer workflow consistency, staff familiarity, and simplified supply management compared with mixing connector systems from multiple manufacturers.

Typical User Profile and Application Scenarios

The typical users of the BD 20558E include registered nurses, infusion nurses, oncology nurses, vascular access specialists, emergency department clinicians, anesthesia teams, pharmacy-prepared infusion staff, and other trained healthcare professionals responsible for IV access and medication administration.

This connector is most relevant in clinical situations requiring sterile needle-free access, multiple connection points, and dependable IV line management. Common scenarios include intermittent IV medication administration, direct injection, continuous infusion access, line access during patient care, and connector standardization within infusion therapy departments.

Best Practices for Use and Maintenance

  • Store the product in a clean, dry medical supply area according to facility storage requirements.
  • Keep the connector in its original packaging until ready for use.
  • Check expiration date, packaging integrity, connector configuration, and product reference number before opening.
  • Use only with compatible luer and SmartSite-enabled systems as directed by facility policy and manufacturer labeling.
  • Disinfect the access surface thoroughly before each access according to institutional protocol.
  • Avoid touching sterile connection surfaces during setup and administration.
  • Do not force incompatible connections, as this may damage the connector or compromise the fluid path.
  • Replace the connector according to facility policy, manufacturer instructions, medication requirements, and patient-specific clinical needs.
  • Discard after use and do not attempt to clean, reuse, or resterilize the device.

Regulatory and Safety Information

The BD 20558E is intended for professional healthcare use by trained personnel. It should be used only according to manufacturer instructions, accepted infusion therapy standards, medication labeling, and institutional protocols. As a sterile fluid path device, improper handling, reuse, or use with incompatible systems may increase the risk of contamination, leakage, misconnections, device damage, or compromised patient safety.

Do not use the product if the package is damaged, if the connector appears compromised, if the product is expired, or if the configuration does not match the intended clinical application. Because there is a priming volume discrepancy between some distributor listings and BDs official product page, facilities should verify the current product label before ordering for volume-sensitive applications. :contentReference[oaicite:3]{index=3}

How to Order

Select the BD 20558E SmartSite Tri-Port Connector, 0.46 ml PV and add it to your cart. Complete checkout with your preferred shipping and payment options. For bulk orders, quotes, or further assistance, contact CIA Medical customer service at (312) 275-5850 or use the contact form on this page.

Related Products